BBR Partners’s Kronos Bio KRON Stock Holding History

BBR Partners’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-163,236	Closed	-$2.22M	–	262
2021 Q4	$2.22M	Hold	163,236	–	–	0.26%	48
2021 Q3	$3.42M	Sell	163,236 -553	-0.3%	-$11.9K	0.28%	33
2021 Q2	$3.92M	Buy	+163,789	New	+$4.15M	0.31%	30

Other funds holding KRON

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BBR Partners's KRON Position: Q1 2022 in Review

BBR Partners sold out of Kronos Bio (KRON) in Q1 2022, closing a stake of 163,236 shares — an estimated $2.22M sold.

BBR Partners first reported a position in KRON in Q2 2021 and held it in 3 quarters. The position peaked at $3.92M in Q2 2021. 96 funds tracked by Wall St. Rank hold KRON as of Q1 2022.

BBR Partners reported no remaining Kronos Bio position as of Q1 2022 after selling out during the quarter.
BBR Partners sold 163,236 Kronos Bio shares in Q1 2022, an estimated $2.22M.
BBR Partners first reported a position in Kronos Bio in Q2 2021 and held it in 3 quarters.
BBR Partners's Kronos Bio position peaked at $3.92M in Q2 2021.
96 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2022.

Based on BBR Partners's 13F filing for Q1 2022, filed 16 May 2022.